Hak Choy
Impact in
- Radiation top 0.1%
- Advanced Radiotherapy Techniques
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
- Lung Cancer Treatments and Mutations
- Radiation Therapy and Dosimetry
Papers in
-
- Lung Cancer Diagnosis and Treatment 84
- Radiation Therapy and Dosimetry 21
- Lung Cancer Treatments and Mutations 14
- Brain Metastases and Treatment 11
- Oncology 26
- Co-authors
- Robert D Timmerman (32 shared papers)Puneeth Iyengar (19 shared papers)Walter John Curran (18 shared papers)Rebecca Paulus (14 shared papers)Elizabeth Gore (13 shared papers)Steven E. Schild (6 shared papers)Chen Hu (7 shared papers)Maria Werner‐Wasik (10 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (30 papers)Journal of Clinical Oncology (12 papers)Journal of Thoracic Oncology (12 papers)Clinical Lung Cancer (10 papers)JAMA Oncology (8 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Hak Choy
186 papers receiving 12.9k citations
Hak Choy's Hit Papers
Peers
Comparison fields: 5 of 126
- Radiation 2.5k
- Pulmonary and Respiratory Medicine 7.9k
- Oncology 2k
- Radiology, Nuclear Medicine and Imaging 1.1k
- Cancer Research 409
Countries citing papers authored by Hak Choy
This map shows the geographic impact of Hak Choy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hak Choy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hak Choy more than expected).
Fields of papers citing papers by Hak Choy
This network shows the impact of papers produced by Hak Choy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hak Choy. The network helps show where Hak Choy may publish in the future.
Co-authors
The 25 scholars most cited alongside Hak Choy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study Hit paper breakdown → | 2015 | 1629 |
| 2 | Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer Hit paper breakdown → | 2017 | 816 |
| 3 | Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial Hit paper breakdown → | 2016 | 599 |
| 4 | Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer Hit paper breakdown → | 2019 | 439 |
| 5 | Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial Hit paper breakdown → | 2019 | 396 |
| 6 | 2005 | 352 | |
| 7 | PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer Hit paper breakdown → | 2016 | 346 |
| 8 | A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927) Hit paper breakdown → | 2015 | 327 |
| 9 | Consideration of Dose Limits for Organs at Risk of Thoracic Radiotherapy: Atlas for Lung, Proximal Bronchial Tree, Esophagus, Spinal Cord, Ribs, and Brachial Plexus Hit paper breakdown → | 2010 | 304 |
| 10 | 2010 | 303 | |
| 11 | Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer Hit paper breakdown → | 2018 | 290 |
| 12 | 2013 | 277 | |
| 13 | 2014 | 247 | |
| 14 | 2010 | 237 | |
| 15 | 2010 | 230 | |
| 16 | 2018 | 213 | |
| 17 | 2018 | 197 | |
| 18 | 1993 | 195 | |
| 19 | 2008 | 187 | |
| 20 | A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. | 2001 | 165 |
About Hak Choy
Hak Choy is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiation, Radiology, Nuclear Medicine and Imaging and Pharmacology, having authored 187 papers that have together received 13.3k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (84 papers), Radiation Therapy and Dosimetry (21 papers), Advanced Radiotherapy Techniques (15 papers), Lung Cancer Treatments and Mutations (14 papers), Brain Metastases and Treatment (11 papers), Effects of Radiation Exposure (10 papers), Inflammatory mediators and NSAID effects (9 papers) and Cancer therapeutics and mechanisms (8 papers). The work is most often cited by research in Radiation (2.5k citations), Pulmonary and Respiratory Medicine (7.9k citations), Oncology (2k citations), Radiology, Nuclear Medicine and Imaging (1.1k citations) and Cancer Research (409 citations). Hak Choy has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Robert D Timmerman, Puneeth Iyengar, Walter John Curran, Rebecca Paulus, Elizabeth Gore, Steven E. Schild, Chen Hu, Maria Werner‐Wasik, Kenneth D. Westover and Ritsuko U Komaki. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Journal of Thoracic Oncology, Clinical Lung Cancer and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.